News LCT files Pre-IND Request Letter with FDA for its NeurotrophinCell Product Living Cell Technologies Limited (ASX: LCT) today announced that it has filed a request for a Pre-IND Meeting with the FDA to seek guidance and feedback on the development program for its NeurotrophinCell product. Related Document |